Australia Gives Nod To A New Cholangiocarcinoma Treatment
Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The Therapeutic Goods Administration...
CHMP Endorses Beyfortusfrom Sanofi And Astrazenecas For RSV
Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to treat lower respiratory tract...
canSERV Offers Cancer Research Solutions Throughout Europe
Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business...
Use of 2 COVID Therapies Is Highly Discouraged By The WHO
The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and the variant's most recent...
Cambodian Drugmakers Have Few Options Despite Rising Illness
Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in Cambodia will remain restricted,...
BioMarin, CSL- Haemophilia Gene Treatments Win ICER Backing
Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a...
WHO Advocates For More Research For Long COVID Patients
The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously.
At least 17 million...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...